"uuid:ID","instanceType","id","label","name","description","text"
"2514139a-9f5f-46ba-bb31-6a4f3128bfda","OBJECTIVE","Objective_1","","OBJ1","Main objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"e934c369-6860-4725-aad3-73af28c8cf41","OBJECTIVE","Objective_2","","OBJ2","Safety","To document the safety profile of the xanomeline TTS."
"ca68e618-7034-40e8-836a-210c93986924","OBJECTIVE","Objective_3","","OBJ3","Behaviour","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
